About
About Heilongjiang ZBD Pharmaceutical Co., Ltd
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the pharmaceuticals business in China. The company researches, develops, produces, and sale traditional Chinese medicine preparations, biological agents, and chemical agents, as well as involved in the pharmaceutical and Chinese medicinal materials trade; and leasing business. It also engages in pharmaceutical manufacturing; contract manufacturing of pharmaceuticals; pharmaceutical retail and wholesale; testing and inspection services; pharmaceutical internet information services; laboratory animal production; and laboratory animal management. The company offers medicines in the field of cardiovascular and cerebrovascular, anti-infectives, respiratory system drugs, tumors, and antiviral drugs diseases. Heilongjiang ZBD Pharmaceutical Co., Ltd. was founded in 1996 and is based in Harbin, China.
Visit company website
5 years, 5 months ago
Heilongjiang ZBD Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 22.4% above its 200 day moving average.
From a valuation standpoint, the stock is 60.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.
Heilongjiang ZBD Pharmaceutical Co., Ltd's total revenue sank by 35.8% to $412M since the same quarter in the previous year.
Its net income has dropped by 44.2% to $56M since the same quarter in the previous year.
Finally, its free cash flow fell by 119.2% to $-218M since the same quarter in the previous year.
Based on the above factors, Heilongjiang ZBD Pharmaceutical Co., Ltd gets an overall score of 2/5.